XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Total revenue $ 86,455 $ 7,686 $ 6,308
Operating costs and expenses:      
Cost of revenues 2,159 813 553
Research and development 356,235 326,163 283,166
Selling, general and administrative 274,524 227,699 183,498
Restructuring 33,386    
Total operating costs and expenses 666,304 554,675 467,217
Loss from operations (579,849) (546,989) (460,909)
Interest income, net 38,743 14,190 2,883
Other income (expense), net (383) 15 134
Net loss $ (541,489) $ (532,784) $ (457,892)
Net loss per share - basic $ (9.05) $ (8.98) $ (7.8)
Net loss per share - diluted $ (9.05) $ (8.98) $ (7.8)
Weighted average number of common shares outstanding—basic 59,836,441 59,306,094 58,670,230
Weighted average number of common shares outstanding—diluted 59,836,441 59,306,094 58,670,230
Comprehensive loss:      
Net Income (Loss) $ (541,489) $ (532,784) $ (457,892)
Other comprehensive items:      
Unrealized gain (loss) on marketable securities 9,392 (7,546) (3,075)
Total comprehensive loss (532,097) (540,330) (460,967)
Product Revenue [Member]      
Total revenue 10,454 $ 7,686 $ 6,308
License And Milestone Revenue - Related Party [Member]      
Total revenue 75,000    
Collaboration Revenue - Related Party [Member]      
Total revenue 824    
Other Collaboration Revenue [Member]      
Total revenue $ 177